Login / Signup

Eliminating MRD - FDA approval of blinatumomab for B-ALL in complete remission.

Talal HilalVinay Prasad
Published in: Nature reviews. Clinical oncology (2019)
Keyphrases
  • acute lymphoblastic leukemia
  • drug administration
  • disease activity
  • ulcerative colitis
  • rheumatoid arthritis